M&A Deal Summary

Getinge Acquires Paragonix Technologies

On August 22, 2024, Getinge acquired medical products company Paragonix Technologies from Signet Healthcare Partners

Acquisition Highlights
  • This is Getinge’s 7th transaction in the Medical Products sector.
  • This is Getinge’s 7th transaction in the United States.
  • This is Getinge’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2024-08-22
Target Paragonix Technologies
Sector Medical Products
Buyer(s) Getinge
Sellers(s) Signet Healthcare Partners
Deal Type Add-on Acquisition
Advisor(s) UBS Investment Bank (Financial)
Sheppard Mullin (Legal)

Target

Paragonix Technologies

Waltham, Massachusetts, United States
Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Getinge

Gothenburg, Sweden
Category Company
Founded 1904
Sector Medical Products
Employees11,891
Revenue 31.8B SEK (2023)
DESCRIPTION

Getinge is a medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge was founded in 1904 and is based in Gothenburg, Sweden.

DEAL STATS #
Overall 11 of 11
Sector (Medical Products) 7 of 7
Type (Add-on Acquisition) 10 of 10
State (Massachusetts) 1 of 1
Country (United States) 7 of 7
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-11 Healthmark

Fraser, Michigan, United States

Healthmark is a provider of instrument care and infection control consumables. Healthmark was founded in 1969 and is based in Fraser, Michigan.

Buy $320M

Seller(S) 1

SELLER

Signet Healthcare Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1998
PE ASSETS 600M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-16 Curida

Oslo, Norway

Curida offers contract development and manufacturing solutions to European pharmaceutical and biotech companies globally. Curida was founded in 2015 and is based in Oslo, Norway.

Buy -
Mergr

Product

Company

Legal